DD
Deval Devidas Bamane
About Deval Devidas Bamane
Data last updated:
Deval Devidas Bamane is a Director at Shuddha Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Shuddha Pharmaceuticals Private Limited reported revenue of ₹23,000 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Aug 2020 | 2020 | ₹23,000 (FY 2025) | Active |
Board colleagues of Deval Devidas Bamane
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandip Bhikulal Katke | 08846859 | Shuddha Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deval Devidas Bamane
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deval Devidas Bamane
Deval Devidas Bamane currently holds 1 directorship: Shuddha Pharmaceuticals Private Limited (Director, since 24 Aug 2020, revenue ₹23,000 (FY 2025)).
Deval Devidas Bamane was first appointed on 24 Aug 2020 as Director at Shuddha Pharmaceuticals Private Limited.
The current boards of Deval Devidas Bamane's companies include Sandip Bhikulal Katke (Shuddha Pharmaceuticals Private Limited).